Author: Japan America Society of Greater Philadelphia

Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium

June 26, 2026
Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium

June 11, 2026

Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium